Danazol for fibrocystic disease of the breast
Medical Letter on Drugs and Therapeutics 23(2): 5-6
1981
ISSN/ISBN: 0025-732X PMID: 7007846 Document Number: 179784
Document emailed within 1 workday
Related Documents
Gorins, A.; Perret, F.; Tournant, B.; Rogier, C.; Lipszyc, J. 1984: A French double-blind crossover study (danazol versus placebo) in the treatment of severe fibrocystic breast disease European Journal of Gynaecological Oncology 5(2): 85-89Godfrey, S.E. 1986: Is fibrocystic disease of the breast precancerous? Archives of Pathology and Laboratory Medicine 110(11): 991
Gibson, W.J. 1988: The relationship of fibrocystic disease to breast carcinoma Journal of the Mississippi State Medical Association 29(5): 137-139
Andrews, W.C. 1990: Hormonal management of fibrocystic disease of the breast Journal of Reproductive Medicine 35(1 Suppl): 87-90
Dambrosio, F.; Dibisceglia, G.; Colombo, A. 1989: Treatment of fibrocystic mastopathy with danazol (100mg/day) studied by thermo-echo-clinical examination Annali di Ostetricia Ginecologia Medicina Perinatale Spec No: 44-57
Alonzo-Sosa, J.E.; Cárdenas-Bazan, M.A.; Dávila-Velazquez, J.; Santiago-Ponce, L.M. 1996: Prevalence of fibrocystic disease of breast in patients with endometriosis Ginecologia y Obstetricia de Mexico 64: 283-285
Wu, C.; Ray, R.M.; Lin, M.Gang.; Gao, D.Li.; Horner, N.K.; Nelson, Z.C.; Lampe, J.W.; Hu, Y.Wei.; Shannon, J.; Stalsberg, H.; Li, W.; Fitzgibbons, D.; Porter, P.; Patterson, R.E.; Satia, J.A.; Thomas, D.B. 2004: A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000 American Journal of Epidemiology 160(10): 945-960
Pastides, H.; Kelsey, J.L.; LiVolsi, V.A.; Holford, T.R.; Fischer, D.B.; Goldenberg, I.S. 1983: Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology Journal of the National Cancer Institute 71(1): 5-9
Page, D.L.; Vander Zwaag, R.; Rogers, L.W.; Williams, L.T.; Walker, W.E.; Hartmann, W.H. 1978: Relation between component parts of fibrocystic disease complex and breast cancer Journal of the National Cancer Institute 61(4): 1055-1063
Kociałkowski, K.; Otworowski, A. 1992: Cystectomy accompanied by immediate examination as the preferred method of treating fibrocystic breast disease Ginekologia Polska 63(1): 26-27
Karelina, T.V.; Ermilova, V.D.; Rukosuev, V.S.; Kazantseva, I.A. 1982: Immunocytochemical study of the myoepithelial cells in fibrocystic disease and ductal carcinoma of the breast Arkhiv Patologii 44(12): 29-35
Mansel, R.E.; Wisbey, J.R.; Hughes, L.E. 1979: The use of danazol in the treatment of painful benign breast disease: preliminary results Postgraduate Medical Journal 55(Suppl 5): 61-65
Beyrouti, M.I.; Beyrouti, R.; Khabir, A.; Ben Amar, M.; Frikha, F.; Dhieb, N.; Damak, D.; Abid, M.; Affes, N.; Boujelben, S.; Frikha, M. 2006: Fibrocystic mastopathy and cancer of the breast. about 111 cases La Tunisie Medicale 84(10): 626-631
Sieja, K.; Stanosz, Sław. 2002: The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast Ginekologia Polska 73(7): 594-599
Peters, T.G.; Lewis, J.D. 1976: Treatment of breast cancer with danazol Surgical Forum 27(62): 97-98
Coombes, R.C.; Dearnaley, D.; Humphreys, J.; Gazet, J.C.; Ford, H.T.; Nash, A.G.; Mashiter, K.; Powles, T.J. 1980: Danazol treatment of advanced breast cancer Cancer Treatment Reports 64(10-11): 1073-1076
De León Antoni, E. 1989: Is fibrocystic disease precancerous? Boletin de la Asociacion Medica de Puerto Rico 81(11): 451-454
Sur, P. 1989: Experience with danazol in the treatment of advanced breast cancer Journal of the Indian Medical Association 87(3): 71-72
Gateley, C.A.; Maddox, P.R.; Courtney, S.P.; Mansel, R.E. 1995: The effect of danazol on discrete benign breast lumps Journal of the Royal College of Surgeons of Edinburgh 40(6): 371-373
Watt-Boolsen, S.; Emus, H.C.; Junge, J. 1982: Fibrocystic disease and mastalgia. a histological and enzyme-histochemical study Danish Medical Bulletin 29(5): 252-254